Page 11234..1020..»

Archive for the ‘Preventative Medicine’ Category

New Preventative Medicine Facility Wraps Work in NYC – Healthcare Construction and Operations News

Sunday, November 7th, 2021

By HCO Staff

NEW YORK CITYWare Malcomb, an award-winning international design firm, recently announced construction is complete on Princeton Longevity Center, a preventive medicine facility located at 1 World Trade Center. Ware Malcomb provided the interior architecture and design services for the project.

The 10,000-square-foot facility is a new build-out that includes a 2,000-square foot-imaging-diagnostic licensing suite, including advanced technology imaging rooms and a CT scan room. The space also includes a reception area, a lounge, individual patient rooms, exam rooms, offices, and a fitness room. The design is hospitality-focused and mirrors the aesthetic established at their Princeton, New Jersey location.

Princeton Longevity Center is extremely patient-centric in all of their decisions, said Marlyn Zucosky, Regional Director, Interior Architecture & Design for Ware Malcomb. We were pleased to work closely with them to design a facility to enhance their patients experience and wellness. The result is a highly-functional, relaxing and beautiful space in one of the worlds highest-profile buildings.

At the entrance to the suite, a virtual receptionist assists guests with check-in. The inviting lounge offers spectacular views from the 71st floor of the 1 World Trade Center and incorporates wood-look luxury vinyl tile flooring, as well as a curved reception desk with backlit features. A custom hand-woven rug, a unique light fixture and a custom millwork coffee bar add a hospitality vibe to the spacious waiting area.

Individual patient rooms provide guests with a private space while they spend the day at Princeton Longevity Center and include computers, showers and a relaxing lounge atmosphere. The exam rooms and doctor offices, which also provide views of the city, incorporate calming colors. The rich tones of the design color palette are a dramatic contrast to the natural light provided by floor-to-ceiling windows.

The general contractor was Icon Interiors, Inc. The project achieved LEED Gold certification, a requirement of all 1 World Trade Center tenants. This is Ware Malcombs second project for Princeton Longevity Center; the first was their Princeton, NJ location, completed four years ago. Princeton Longevity Center is a leader in the preventive medicine market, offering the most advanced technology services and serving C-suite clientele with comprehensive medical evaluations.

Here is the original post:
New Preventative Medicine Facility Wraps Work in NYC - Healthcare Construction and Operations News


Cornell grad and lecturer touts benefits of plant-based diet –

Sunday, November 7th, 2021

If there is one piece of advice that 87-year-old Dr. T. Colin Campbell would give to those looking to age well and stay healthier longer, it would be to change your diet to a plant based, whole food approach.

The idea of plant based eating has gained popularity in recent years, but it was first coined by Campbell back in 1978. The bestselling coauthor of The China Study (published in 2006) said it has been exciting to see it gain traction in the last several years.

Its interesting because the idea of a plant based diet possibly being the best and the way of the future is just beginning to take hold in the mainstream public, Campbell said.

His recommendation that most everyone can adopt a plant based diet and have it benefit their lives hinges on a discovery he made early in his career: that people do not need to eat animal protein in order for their bodies to get the protein they need.

For the son of a dairy farmer, this flew in the face of what he had believed growing up but the evidence that a plant based diet can prevent and, in the vast majority of cases, even reverse common American ailments like diabetes, high cholesterol and heart disease was so strong that he dedicated his career to researching it and publicly sharing his findings. He has also worked to shape public policy around health and nutrition and was the liaison to Congress for the medical research community in 1980 and 1981.

Campbell wasnt always interested in studying nutrition. He was completing his first year of veterinary school when he received a telegram from a well known Cornell Professor offering him a scholarship and research opportunity, which led him to complete his education at Cornell University and MIT in the field of nutrition, biochemistry and toxicology. During his time at Cornell, around 1965, he was tasked with coordinating an effort to aid malnourished children in the Philippines. It was believed at the time that the children needed more animal protein to be healthy, but what Campbell found instead was that the few children who came from families who were able to consume more animal protein had a higher rate of liver cancer than their peers.

I couldt quite believe what I was seeing, Campbell said. I had many students work in the lab on this question and over the years found that there is no need to consume animal food to get that protein. That is totally false.

Campbell spent a decade on the faculty of Virginia Techs Department of Biochemistry and Nutrition, then returned to Cornell in 1975, where he currently holds his endowed chair as a professor emeritus of nutritional biochemistry in the Division of Nutritional Sciences.

In recent years Campbell founded a non-profit organization on online learning in nutrition which recently developed, under the direction of Campbells daughter LeAnne Campbell, the program Plant Forward, which holds online workshops.

The workshops teach a simple philosophy that can be difficult to put into practice at first but pays great dividends if the individual can stick with it for a month or two, Campbell said.

The people who stay with it are often people who have a serious health problem or have a motivation, he said. Sometimes the effects are almost immediate.

People can see their blood sugar drop precipitously in one day, he said. Its amazing.

The key is to go all-in on the new diet. He likened it to quitting smoking just cutting down to one or two cigarettes per day or smoking on some days but not on others is not likely to lead to success in the longterm. But soon, Campbell said, this new kind of eating will become second nature and even enjoyable.

Youll all of a sudden discover you crave a salad, he said. Just eat vegetables, grains, nuts, and avocados for the oil and fat.

As much as possible, stay away from added oils and refined carbs, he added.

The effects of adopting a whole plant-based diet are striking, he said.

We can turn experimental liver cancer genes on with animal based protein and turn it off by eating a plant based diet, he said.

Campbells own father died of a heart attack when he was 70, and his wifes mother died of colon cancer when she was just 51. That motivated us to think about changing our diet, so we did, he said. His wife is 80 years old, and both are largely medication free other than a short period Campbell spent on medication to control his blood pressure.

Campbells first book, The China Study, came out of a partnership in the 1980s with researchers at Oxford University and the Chinese Academy of Preventative Medicine and sold nearly four million copies worldwide. Campbell followed that up with his second book, Whole, in 2013, which is focused on the science behind plant based eating.

In 2020 he published The Future of Nutrition: An Insiders Look at the Science, Why We Keep Getting it Wrong, and How to Start Getting It Right.

He still gives lectures and is involved with the online Plant-Based Nutrition Certificate in Partnership with eCornell. His research is the cornerstone of the 2011 documentary film Forks Over Knives, and his oldest son, Nelson Campbell, made another popular documentary on the topic called Plant Pure Nation.

Some advice that he received from his father that has guided him throughout his life: Tell the truth, the whole truth, and nothing but the truth. It is a philosophy that allowed him to question his original assumption that eating animals must be good for health.

The key is to be honest with yourself and check your own biases, he said. Thats really critical.

See original here:
Cornell grad and lecturer touts benefits of plant-based diet -


MPD working with faith-based leaders to fight violent crime – FOX13 Memphis

Sunday, November 7th, 2021

MEMPHIS, Tenn. Across Memphis, there have been at least 270 homicides compared to 263 at the same time last year. With less than two months left in the year, the city is on pace to shatter last years record.

In an effort to slow things down, MPD is working on getting to the source of violent crime.

Faith-based leaders have partnered with law enforcement to offer resources. The goal is for officers not just to respond to crimes but also to stop them before they start.

Preventative medicine is the best form of medicine, said Pastor Ricky Floyd with Pursuit of God Church.

To cure a city plagued by violent crime, the Memphis Police Department has partnered with faith-based leaders to get to the root of the problem.

Couples counseling, trauma response, gang talk, domestic violence, conflict resolution. Those are some of the things problematic in our community, said Memphis Deputy Police Chief PaulWright.

Faith-based leaders, MPD, and the U.S. Attorneys Office are hosting the Better Community Summit Saturday. The aim is to connect attendees with experts who specialize in areas Wright described.

Young people have seen things happen in their community now that they dont quite understand.If they dont get that fixed, it may be a problem in the future, Wright said.

Floyd said this summit is vital to lift the community.

Sometimes people think no one is out there to help me. Theres a lot of help available, said Floyd.

The summit isSaturday from 10 a.m. to 2 Pursuit of God Transformation Center in Frayser.


Trending stories:

2021 Cox Media Group

Read more from the original source:
MPD working with faith-based leaders to fight violent crime - FOX13 Memphis


Meet the Cork-born bread activist who has Goldie Hawn buying her loaves – Irish Examiner

Sunday, November 7th, 2021

Karen ODonoghue has a goal: to cure everyone in Ireland of IBS. And, paradoxically, shes aiming to use bread to do it.

Already you can see the bands of gastroenterologists around the country tut-tutting at such a tall order.

Yet, ODonoghue should know a thing or two. In 2018 she was named Gut Specialist of the Year in the UK and she is currently a judge for the World Bread Awards.

Actress Goldie Hawn rates her anti-inflammatory bread so highly that she took ten loaves with her back to the US and claimed it cured both her and her sons Irritable Bowel Syndrome (IBS).

Ears perk.

Every system and organ in the body is dependent on the health of the gut microbiome so when you nourish the microbiome, it automatically nourishes the brain, says ODonoghue from her new bakery in Mayo.

Youll make better decisions in your life, have more energy, and youll enjoy better sex, she adds, with a twinkle.

Eyebrows raise.

Bread activism it kind of has a ring to it.

And this is the business ODonoghue is in, swapping prescriptive medicine for a food-led approach to managing and healing ones own body.

As the founder of the Happy Tummy Company in London in 2014, she is responsible for single-handedly pioneering a scientifically-developed range of breads aimed at alleviating IBS (her UK customers coined the term magic poo bread for how much it helped them), mental health issues, period and menopause pain, and, what she describes as functional rehab for both physical injury and trauma from illness.

The Happy Tummy Company was born out of a deep desire to help others, and in turn, out of illness.

Growing up in Cork where her parents ran a horticulture company, when ODonoghue was 10 years old her mother was diagnosed with cancer.

She vividly remembers the lightning bolt moment that would dictate the course of her future.

Growing up with a mother who had cancer and who ultimately died from it, I was very aware of the part food had to play in our overall wellbeing.

During the time of my mums cancer treatments I remember digging the soil with my dad, planting beech saplings, and I had this epiphany: when Im older Im going to create a brand thats all about food as preventative medicine.

Fast forward to 24-year-old Karen living in London.

Having spent most of her life battling with IBS, she found herself depressed and anxious.

The older I got and the more my IBS became an issue, I knew I needed to go back to that ambition I had as a little girl. Intuitively I always knew that food is medicine.

She started poring over scientific research papers to learn about the gut microbiome and discovered that our gut bacteria works to a specific mathematical equation: we should be eating 66% dietary fibre to 33% dietary protein and five grams of prebiotic fibre every day.

Based on this, she created her own formula (her father was a maths teacher they regularly discussed theorems at the dinner table) and applied it to the bread making process.

It was during this time that she discovered a gluten-free grain from Africa.

The star ingredient is teff, grown in Ethiopias highlands, which is high in protein, calcium and iron, along with prebiotic fibres and antioxidants, all of which stimulate the growth of good gut bacteria, reduce inflammation and nourish the lungs, brain, skin, and nervous system. Teff relieves bloating and constipation and also helps to balance hormone levels, stimulate digestion and strengthen bones.

After 18 months of a mad scientist-like existence in her London flat she developed a loaf of bread that would completely rid her of her IBS.

From having one bowel movement every three weeks, within a week she was doing two poos a day.

The shape of her tummy changed, her depression and anxiety disappeared and she started to feel alive again.

That loaf is now her best-selling Chia Teff Loaf, aka the magic poo bread

In 2014 she established her London bakery, The Happy Tummy Company (cue Goldie Hawn and many more high-profile followers) in Hackney and a school where she taught students how to use food both as preventative and prescriptive medicine.

The bread-making process started as a means to cure her own IBS but once the word got out, loaves were flying off the shelves like IBS-crusading hotcakes.

Last year, after 13 years in the UK, she decided to relocate the business headquarters to Westport in Mayo.

ODonoghue walks the talk. She beams of health and is genuinely positive, which is infectious to be around.

ODonoghue believes we need to pare back how we look at bread and start viewing our consumption of it primarily from a health perspective, and flavour as a secondary issue.

The reason bread has a branding problem, she believes, is because bakers are obsessed with the aesthetics of what they are making over nourishment, creating white, fluffy sourdough breads using commercial wheat.

Consumers, particularly those who have issues with gluten or coeliac disease, eat these breads and all of a sudden feel bloated, lethargic, and agitated. And thats not surprising.

You are eating a wheat that is not very natural.

The Chia Teff Loaf takes about three days to make and is packed with organic teff (so no herbicides or pesticides), sprouted buckwheat, walnuts, Brazil nuts, almonds, linseed, and chia seeds all expensive ingredients.

It costs 25 per loaf.

As a bakery we are not yet making money and Ive had to fight an industry that has brainwashed people into thinking that food can be cheap.

I know its generally not politically correct to go so hard on this organic way of eating because people will argue that it is elitist, privileged and only a certain percentage can afford organic food.

But when I had the bakery in Hackney we had loads of customers who were on the breadline buying our bread because they fundamentally understood the importance of organic, wholegrain food in their diet.

This month ODonoghue launches her 48-hour soaked wholegrain Chia Teff Loaf, aka the magic poo bread, to the Irish market on a nationwide delivery service.

She also runs baking classes at her school house, Teach Scoile, in Westport to educate people on the benefits of teff.

As a baker, she separates bread makers into two camps.

There are those who nourish, and there are those who feed, she says.

And Ive always wanted to nourish.

When I had that epiphany at 10 years of age I knew that this brand will be more of a vocation than a business.

What Im doing here is a vocation about preventative medicine to give every single person suffering with IBS access to food and education that works.

Meet the Cork-born bread activist who has Goldie Hawn buying her loaves - Irish Examiner


Pfizer says pill cuts risk of severe Covid by 89% –

Sunday, November 7th, 2021

A trial of Pfizer's experimental antiviral pill for Covid-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalisation or death for adults at risk of developing severe disease, the company said.

The results appear to surpass those seen with Merck's pill molnupiravir, which was shown last month to halve the likelihood of dying or being hospitalised for Covid-19 patients also at high risk of serious illness.

Full trial data is not yet available from either company.

Professor Luke O'Neill said the new drug is "very significant" because the manufacturer got 89% efficacy in their trial.

The Trinity immunologist added: "What that means is 9 out of 10 people wouldn't end up in hospital with Covid. If that turns out to be true once it's launched that would be remarkable.

He said this disease is an emergency and Pfizer is applying for emergency use in the United States with the FDA and also with the European Medicines Agency (EMA).

"Those agencies will look very closely at the data and the safety and they will be really under pressure now approve these drugs because an antiviral is a great extra weapon to use against this virus," Prof O'Neill said.

Separately, the Tnaiste has said a new antiviral oral pill for Covid will be a "very valuable weapon" and he hopes it can be approved by the EMA "quite soon".

Yesterday, the UK medicines regulator became the first to approve the drug 'Molnupiravir', for people who have had a positive Covid test and have at least one risk factor for developing severe illness, such as obesity, being over the age of 60, diabetes or heart disease, something Leo Varadkar said was "really encouraging".

Mr Varadkar said: "Once you are diagnosed you can take this tablet and it reduces by up to half the chances of you needing to be hospitalised, so that can really make a big difference.

"I hope the EMA will approve that quite soon, because you can never deal with a virus through vaccination alone, you need therapeutics too and you need preventative medicine.

"This is going to give us an extra weapon in our armoury and a very valuable weapon too," he added.

Pfizer will now submit interim trial results for its pill, which is given in combination with an older antiviral called ritonavir, to the US Food and Drug Administration as part of the emergency use application it opened in October.

The combination treatment, which will have the brand name Paxlovid, consists of three pills given twice daily.

A spokesperson from Pfizer in Ireland said that the company's plant in Ringaskiddy "will support the global manufacturing and supply" of the drug, if it is given approval.

He said: "Pfizer has begun investing prior to regulatory authorisation in the manufacture of our potential Covid-19 oral antiviral candidate to help bring this potential treatment to patients as soon as possible.

"Pfizer's site in Ringaskiddy has a successful history of contributing to our manufacturing efforts."

We need your consent to load this rte-player contentWe use rte-player to manage extra content that can set cookies on your device and collect data about your activity. Please review their details and accept them to load the content.Manage Preferences

The planned analysis of 1,219 patients in Pfizer's study looked at hospitalisations or deaths among people diagnosed with mild to moderate Covid-19 with at least one risk factor for developing severe disease, such as obesity or older age.

It found that 0.8% of those given Pfizer's drug within three days of symptom onset were hospitalised and none had died by 28 days after treatment.

That compared with a hospitalisation rate of 7% for placebo patients. There were also seven deaths in the placebo group.

Rates were similar for patients treated within five days of symptoms - 1% of the treatment group was hospitalised, compared with 6.7% for the placebo group, which included ten deaths.

Antivirals need to be given as early as possible, before an infection takes hold, in order to be most effective. Merck tested its drug within five days of symptom onset.

"We saw that we did have high efficacy, even if it was five days after a patient has been treated ... people might wait a couple of days before getting a test or something, and this means that we have time to treat people and really provide a benefit from a public health perspective," said Annaliesa Anderson, head of the Pfizer programme.

The company did not detail side effects of the treatment, but said adverse events happened in about 20% of both treatment and placebo patients.

"These data suggest that our oral antiviral candidate, if approved by regulatory authorities, has the potential to save patients' lives, reduce the severity of Covid-19 infections, and eliminate up to nine out of ten hospitalisations," said Pfizer Chief Executive Albert Bourla.

Infectious disease experts stress that preventing Covid-19 through wide use of vaccines remains the best way to control the pandemic, but only 58% of Americans are fully vaccinated and access in many parts of the world is limited.

Pfizer's drug, part of a class known as protease inhibitors, is designed to block an enzyme the coronavirus needs in order to multiply.

Merck's molnupiravir has a different mechanism of action designed to introduce errors into the genetic code of the virus.

Merck has already sold millions of courses of the treatment, which was approved this week by UK regulators, to the US, the UK and others.

Britain said earlier this month it had secured 250,000 courses of Pfizer's antiviral.

Pfizer is also studying whether its pill could be used by people without risk factors for serious Covid-19 as well as to prevent coronavirus infection in people exposed to the virus.

Read more:
Pfizer says pill cuts risk of severe Covid by 89% -


The roots of ivermectin mania: How South America incubated a fake-medicine craze that took the US by storm – Yahoo News

Sunday, November 7th, 2021

A supporter of President of Brazil Jair Bolsonaro waves a box of ivermectin at a pro-government demonstration in Brasilia in May 2021. Andressa Anholete/Getty Images

The popularity of unproven anti-parasitic drug ivermectin as a COVID-19 treatment is surging.

Its use has roots in South America, where it was hyped by populist leaders citing debunked research.

"Nobody paid attention... now we see the same" in the US, a Peruvian official told Insider.

In May 2020, when the coronavirus was sweeping the South American nation of Peru, Dr. Patricia Garcia of the country's health ministry began receiving disturbing reports from the country's hospitals.

They detailed injuries not caused by COVID-19, but a drug people thought would help them: the anti-parasitic substance ivermectin.

"The kind of things they were telling was people that were coming with severe gastritis [stomach inflammation], and also pancreatitis, because they were taking the ivermectin in desperation," Garcia told Insider.

As the coronavirus continued to spread, people's faith in ivermectin as a way out of the crisis grew more fervent, said Garcia.

It would be almost a year before ivermectin would become widely discussed in the US, as a subset of Americans began to insist on receiving it.

The US demand for ivermectin surged as vaccination - the most effective COVID countermeasure - became increasingly politicized. Doctors strongly advise against taking it but, as of October 16, more than two-dozen lawsuits had been filed around the US from people demanding access to it.

"History is repeating," said Garcia. "Nobody paid attention about what was happening in Latin America and now we see the same situation."

A municipal worker sprays disinfectant past a street vendor at a market in Puno, Peru, near the border with Bolivia, on June 10, 2020. CARLOS MAMANI/AFP via Getty Images

In the Peru of May 2020, there were no vaccines, and ivermectin's rise was being driven by hope and desperation.

Pharmacies fast ran out of pills as thousands sought to obtain it, and a lucrative ivermectin black market emerged, as local media reported at the time.

Adherents recommended both that healthy people take ivermectin as a preventative, and that it be used to treat COVID-19 after infection.

Story continues

Many resorted to a stronger version of the drug, normally used to deworm horses. That form is taken by injection, and people who took it were left with serious skin lesions, said Garcia.

As the fervor spread, evangelical groups based in southern Peru injected 5,000 people from indigenous communities with the drug.

In some cities, including the capital, Lima, public health officials distributed the stronger, dangerous form of the drug to whole neighborhoods.

The belief that ivermectin could work against COVID-19 is almost as old as the pandemic, predating vaccines and even proper testing.

Almost two years later, there is still no conclusive evidence that ivermectin is effective against COVID-19, and it has been repeatedly debunked, including by the FDA in September.

It said that taking large doses of any kind of ivermectin is dangerous, and that humans should never take drugs intended for treating animals.

Carlos Chaccour, a researcher at the Barcelona Institute for Global Health, pointed to an obscure research paper in early 2020 which appeared to answer the desperate desire for a workable treatment.

The paper drew on data from Surgisphere Corporation, a small research group in Chicago, which published it in April 2020 seeing to establish a link between taking ivermectin and surviving COVID-19.

A pharmacist in Santa Cruz, Bolivia, with doses of ivermectin. Rodrigo Urzagasti/picture alliance via Getty Images

The researchers, who also touted hydroxychloroquine, said the paper's basis was data from thousands of hospitals around the world. Their research was published by top-tier medical journals including The Lancet and The New England Medical Journal.

But doubts soon emerged the authenticity of Surgisphere's data, the credentials of its team, and the methodology they used.

The Lancet and The New England Medical Journal retracted the study after a backlash from the scientific community and an investigation by The Guardian. But by then, said Chaccour, the damage was done.

In summer 2020, government officials in Peru, Bolivia, and Guatemala made ivermectin part of their COVID-19 strategies, often citing the retracted study as evidence.

Chaccour told Insider that the drug was embraced so readily because it seemed to present a simple solution, was relatively cheap, and was already widely used in the region.

He noted that a danger of the drug - perhaps worse than its adverse effects - was that people who believed it to be effective against COVID-19 were more likely to ignore actions that actually work.

"One of the risks of ivermectin is not just the safety, but the hazard of people not using masks or not getting vaccines or not doing social distancing because they think they are protected," he said.

As a second wave of the coronavirus hit South America in the latter half of 2020, ivermectin became more popular still. The city of Cali in Colombia handed it out to all of its COVID patients in late July. Weeks later the state of Chiapas in Mexico followed suit.

In Brazil, South America's most-populous country, the drug was endorsed by the country's populist president, Jair Bolsonaro, and by his allies at a regional and national level.

But it wasn't just politicians. They were riding a wave of social-media misinformation that was still spreading. In groups on Facebook and WhatsApp, misinformation about ivermectin was being shared by millions, experts told Insider.

Among its influential promoters was COMUSAV, a group of renegade medics based in Bolivia, whose core product was a kind of industrial bleach promoted as a miracle cure for a vast array of ailments that included COVID-19.

They pushed ivermectin to their followers across the continent on their Facebook pages, which had tens of thousands of followers.

(Many of the group's pages were removed following an investigation by Insider in March 2021.)

A data analyst, Juan Chamie, was among those who helped to bring the enthusiasm for ivermectin from the populists of South America to their equivalents in the US, experts told Insider.

Chamie claimed to have data showing lower COVID-19 mortality in parts of South America where public health authorities approved ivermectin.

But Chaccour and data scientist Joe Brew have said his analyses are misleading, and ignore other factors that could explain the differences.

"Just because things are associated does not necessarily mean that one thing causes the other," they said.

That hasn't stopped Chamie's analyses being shared widely, until his account was suspended by Twitter.

Among those taking note was Laura Ingraham, primetime host of Fox News' show "The Ingraham Angle."

In December 2020 Ingraham posted a graph of data attributed to Chamie to her 3.8 million followers.

It purported to show a reduction in COVID-19 cases, comparing areas of Chiapas, Mexico, where officials did and did not distribute ivermectin.

Chaccour said that, as with Chamie's other claims, the decrease could be coincidental or due to other factors.

Ingraham already had a history of promoting ivermectin. As far back as March 2020, Ingraham had tweeted about the Surgisphere research that was later debunked.

Chaccour believes that Ingraham's advocacy was a tipping point for ivermectin in the US.

Progressive campaign group Media Matters noted that Ingraham's enthusiasm extended to her widely-viewed Fox News show.

In two episodes in December 2020, Ingraham claimed that medical authorities were conspiring to suppress the substance and ignoring evidence of its effectiveness. Andrew Lawrence, a Media Matters staffer, told Insider that Ingraham was "definitely the leader" among network hosts promoting the substance.

A Fox News spokesperson said in Ingraham's defense that she never explicitly told viewers to take the drug.

In comments to The Washington Post, Ingraham criticized attempts to "silence" scientists with unorthodox messages. "Just like the scientific consensus, the medical consensus is evolving. It changes," she sad.

Chamie also formed contacts with the Front Line Critical Care Alliance (FLCCA), a group of US medics who were influential in pushing ivermectin in the US, as detailed in a September investigation by Insider's Hilary Brueck.

Chamie describes himself as a senior data analyst for FLCCA on his LinkedIn page, and the group cites his research on its website.

The group has been instrumental in brokering ties between the pro-ivermectin movement and Republican lawmakers who promoted the drug.

Last December, Dr Pierre Kory, a member of the group, testified before the US Senate about ivermectin in what one critic, Brown University dean Dr. Ashish Jha, described in The New York Times as a "misinformation super-spreader event."

In a statement to Insider, the FLCCC defended its position on ivermectin, forwarding Insider a list of studies based on anecdotal evidence suggesting that ivermectin may be effective in reducing COVID-19 deaths. These studies are not considered conclusive by experts.

The group did not respond to questions regarding Chamie's research, and Chamie himself did not respond to requests for comment from Insider.

As proponents in the US clamored for wider use of ivermectin, in South America disillusioned officials were reversing their position.

In February Peru removed ivermectin from its COVID treatment protocol altogether because of the absence of evidence that it worked.

"It's incredible for me that we, a whole region, already went through this terrible situation in which lots of people have died," Garcia, the Peruvian official, told Insider.

"They were taking ivermectin because it was known to us, so it was easy for us. And it didn't work."

Read the original article on Business Insider

Read the rest here:
The roots of ivermectin mania: How South America incubated a fake-medicine craze that took the US by storm - Yahoo News


The pandemic exposed Montreal’s inequalities, and residents say it’s time to tackle root causes –

Sunday, November 7th, 2021

What was long suspected was quietly confirmed last month: Montrealers who live in the city's poorest neighbourhoods were more likely to die from COVID-19 at the height of the pandemic.

Now community organizers and experts are turning to how to best address the underlying issues that contributed to the disproportionate impact of the pandemic on the city's lower income, more racialized neighbourhoods.

"It really sheds light on the fact that social inequalities here since long before the pandemic are still here and need to be addressed," said Vronique Nadeau-Grenier, the lead researcher on the study conducted by Montreal public health.

The study, released Oct. 13, found a clear correlation between a neighbourhood's material advantages a metric which includes education and income levels and COVID-19 mortality rates.

The public health agency recommended a multitude of changes to address the underlying disparity in the city.

Some of them can be addressed by the City of Montreal, which is set to hold its municipal electionNov. 6 and 7, and others are more complex issues that involve several levels of government.

They include an increase in pay for low-wage workers and the fostering of more stable workplaces (movement between healthcare workplaces was an early contributor to the spread of COVID-19 in Quebec), increase to the availability of affordable quality housing and improved access to social and health services in disadvantaged areas.

The findings underscore those laid out in a CBC News analysis last year after the city's first wave.

Vulnerable populations, such as people living in low-income households, with precarious employment and in underprivileged neighbourhoods, represented both the most cases and deaths linked to COVID-19.

On average, underprivileged neighbourhoods had twice the number of cases and deaths than more affluent ones.

Marjorie Villefranche, the head of Maison d'Haiti, a community organization in Montral-Nord, said the numbers confirm what she has been saying for more than a year.

"We kept saying it and no one was listening," she said. Villefranche said the pandemic highlighted the lack of services in the area.

Montral-Nord, the report found, has the highest mortality rate of any sector: three times higher than some parts of the West Island.

The borough also has the highest per capita case count in the city: 12,079 cases per 100,000 people, as of Oct. 28.

Parole d'excluEs and Hoodstock, both of which have been calling for more research on pandemic impacts, released their own survey of residents. The report found a gap in health and mental health services, and the need for improved communication with residents.

"What all this highlights is that there needs to be a massive investment for community-based organizations in these poorer neighbourhoods that would lead to better access to health care and social services," said Olivier Bonnet, head of Parole d'excluEs.

Mabel Carabali,an assistant professor in the department of social and preventative medicine at University of Montreal, who holds adjunct position at the Dalla Lana School of Public Health at the University of Toronto, said such dynamics are visible in many cities.

She said the underlying issues have been "neglected for too long" and they need to be put under the microscope long after the municipal election cycle.

In Montreal, the disparity played out during the first three waves of COVID-19. By the summer of 2021, according to the report, the disparity had subsided with the spread of COVID-19 on the decline.

Nicholas King, a professor at McGill University who conducts research in public health ethics and policy, said it would be useful to dig deeper into the causes of that levelling off.

"That may give us some clues for us intervening in the future to try to reduce inequalities in health," he said.

In the meantime, he said the government should commit to more quickly and consistently reporting on health and social inequality.

King touted community groups in the province for stepping up and into the breach by producing the data themselves when they noticed the lag.

He said while experts and governments rely on public health authorities to understand what should be done next, community groups can benefit from the data themselves.

"Often some of the most effective interventions against inequalities are bottom up."

Originally posted here:
The pandemic exposed Montreal's inequalities, and residents say it's time to tackle root causes -


Prior poor mental health linked with higher rates of COVID- study – The Jerusalem Post

Sunday, November 7th, 2021

Several studies have shown that the pandemic took a devastating toll on peoples mental health and impacted other psychiatric conditions, but a novel study looked at things from a different perspective.The investigation, conducted by Yale School of Public Health and published in the American Journal of Preventative Medicine, looked at US nationwide levels of mental health to establish that those with poor mental health prior to the pandemic have a greater likelihood of developing a COVID-19 infection.

Researchers used aggregated data from a survey conducted across 2,839 counties to conclude that between 2010 and 2019, a total of 2,172 counties (77%) experienced significant increases in the average number of poor mental health days, including depression, stress and problems with emotions.

cnxps.cmd.push(function () { cnxps({ playerId: '36af7c51-0caf-4741-9824-2c941fc6c17b' }).render('4c4d856e0e6f4e3d808bbc1715e132f6'); });

Further research revealed that more days of poor mental health in 2019 had a robust association with the rate of COVID-19 infections in 2020, leading researchers to believe that the pandemic did not cause new mental health problems, but rather revealed previously ignored issues.

Analysis revealed that poorer mental health days and COVID rates were driven by a few states-- Arizona, Montana, and Nevada.

Lead investigator Yusuf Ransome expressed hope that the study will encourage conversation about the urgency of mental health care.

We call for policies that strengthen surveillance systems to better capture a range of mental health outcomes in the population, address social inequalities that give rise to poor mental health, and [increase] funding to create, sustain and equitably distribute mental health resources, including wellness care centers across US communities," he said.

Ransome added that the idea for the study was inspired by the height of the pandemic.

"Only a handful of studies examining small fragments of the population had considered the possibility that poor mental health could be contributing to a higher burden of infection rather than vice versa," he said. "We wanted to examine whether these relationships also existed in the general population, address the lack of studies with an ecological-level focus, and produce evidence to strengthen calls for interventions.

Continue reading here:
Prior poor mental health linked with higher rates of COVID- study - The Jerusalem Post


Humans and Hardware: How Special Operations Can Pioneer Wearable Technology – War on the Rocks

Sunday, November 7th, 2021

In 2009, the U.S. Special Operations Command announced that Humans are more important than hardware. But with wearables revolutionizing sports medicine and athletics, the distinction between humans and hardware is less relevant than ever. This means that investing in wearable technology for special operations forces is now the best way to put humans first.

What might this look like? With a small population of elite warfighters in high-stress environments, Special Operations Command can lead the force in determining which wearable devices are worth the investment. The Preservation of the Force and Family program, which is already in place to improve the holistic health of special operations forces, can spearhead efforts to distribute, monitor, test, and best utilize wearables for the entire military.

A Wearable Revolution

In the last two decades, sports medicine and sports science have advanced dramatically. Athletes are now bigger, faster, and stronger due, in part, to advancements in technologies that allow them to train smarter. A critical facet of this revolution is wearable technology that offers athletes immediate and continuous feedback on an increasing number of health and performance metrics. The wearable trend started with simple Global Positioning System-enabled devices measuring steps taken in a day and heart-rate monitors allowing users to train in specific heart-rate zones. However, wearable technology is now quickly outpacing older, more expensive, and more invasive technologies. New Apple Watches, for example, allow users to bypass hospital visits by serving as both an electrocardiogram to monitor heart health and a pulse oximeter to measure blood oxygen levels in 10 seconds. Wearables rapid development is providing valuable new tools for physical therapists and healthcare professionals and eliciting optimism about the future of individualized self-care.

This revolution hasnt gone unnoticed by the Department of Defense, which is testing wearables across different military branches. The U.S. Air Force recently began using the Oura Ring, a technology worn on your finger, to more accurately determine pilots flight readiness in the morning based on their overall sleep score. Previously, pilots flight readiness was determined by hours in bed rather than the quality of sleep. However, Oura Rings offer the ability to both measure sleep quality and potentially improve sleep, making pilots fitter to fly. Additionally, the U.S. Navy regularly tests various wearable devices at the Naval Postgraduate School Human and Systems Integration laboratory to study and improve crew rest, while the U.S. Army tests wearables to study soldiers resiliency in harsh winter conditions. As wearable technology continues to progress, so do the applications and opportunities to improve service members sleep, fitness, and overall health.

Wearables Potential in Special Operations

In 2012, Special Operations Command adopted the Preservation of the Force and Family strategy. The goal was to optimize and sustain mission readiness, longevity, and performance, thereby maximizing the estimated $1.5 million investment that the military makes in each member of special operations. The strategy seeks to provide precise preventative interventions and emphasisizes holistic health across five domains: physical, cognitive, psychological, social and family, and spiritual.

Wearable technology is already improving individual physical fitness and should be a critical component in enhancing operator health across every all of these domains. Wearables currently track a host of physical and biological metrics and use algorithms to generate useful approximations of additional metrics, including sleep quality, readiness, and stress. Many wearable interfaces offer coaching to nudge users towards healthier behaviors. Leading wearables, including the Oura Ring, Apple Watch, and Whoop Strap, offer nuanced sleep and activity coaching based on users unique metrics and trends. Put simply, wearables can tell you when you are overworked and need a break.

In an organization like Special Operations Command, which demands long hours under highly stressful conditions, having a tool that provides an objective measurement of readiness is uniquely valuable. Operators are specially selected and trained for resilience to adverse physical and mental conditions. Constant adaptation to a changing environment, however, comes at a cost. But this advantageous adaptation can produce allostatic load, leading to chronic physical maladies including pain, fatigue, and compromised immunity. Reduction of allostatic load first requires identification of increased stress. Enter wearables. Wearables can provide feedback on a host of biological metrics correlated with stress, including heart-rate variability, resting heart rate, and sleep quality. This makes it possible to identify chronic physiological stress, implement nuanced interventions, and prevent the difficulties associated with allostatic overload.

Wearables can also bring benefits in the cognitive and psychological domains. The Oura Ring encourages users to monitor body signals through practices such as guided mindfulness and breathing protocols. As shown by ongoing studies at Texas A&M, mindfulness meditations and associated breathing exercises can reduce stress and improve mental health. This can be particularly useful to special operations forces in reducing combat mental illness. Paired with blast gauge data or baseline cognitive tests such as the Automated Neuropsychological Assessment Metrics, wearables may also allow the early identification and treatment of traumatic brain injury.

Mitigating Concerns

In a profession where chronic stress is so abundant that it produced the term operator syndrome, why are wearable technologies not already commonplace? For one thing, there isnt a one-size-fits-all wearable. While one wearable specializes in sleep, for example, it may not be as effective at measuring physical activity. Concerns over operational security also dampen wearable enthusiasm in the Defence Department. And for good reasons in 2018, the fitness and location tracking application Strava infamously illuminated the location of multiple overseas military bases. Similarly, privacy risks regarding collected data can cause hesitation in an increasingly connected and data-driven world. Data security and patient confidentiality are paramount concerns with aggregated health information collected from wearables, and have legal implications under the Health Insurance Portability and Accountability Act. While data is routinely stripped of identifiers, including names and addresses, it can become re-identifiable when correlated with other datasets.

Special Operations Command has an important role to play in helping to address these security and privacy concerns. Letting the Preservation of the Force and Family program lead the development of wearables can help by removing military commanders from the loop, preventing mandatory use and giving participants the power of consent. Personnel associated with this program are also trained and certified to handle protected health information, reducing the risk of a Health Insurance Portability and Accountability Act violation and relieving military commanders of such a burden. Assigning random user identifications can help to avoid the disclosure of personal data. Preservation of the Force and Family personnel can further prevent the re-identification of anonymous users by isolating the wearables data, thereby preventing their merging with larger military data sets.

While there are simple ways to mitigate the known concerns over wearables, there will always be risks, especially with the early adoption of technology. These risks should be explored, preferably in a small and competent population, to best identify and understand wearables capabilities and limitations. Implementation and open dialogue will enable the force to exploit wearables significant potential to improve holistic health.

Wearables Are Coming!

In any technological revolution, there will be resistance to adopting new technology, especially in large organizations like Special Operations Command. Nevertheless, wearable technology has taken the world by storm. Large corporations have adopted wearables into healthcare policies, and wearable tech is an $81.5 billion industry. With a smaller population that is often presented with high chronic stress, Special Operations Command has the opportunity to lead the U.S. military in the use of wearable technology. By leveraging the recent revolution in wearables, programs such as Preservation of the Force and Family can bring humans and hardware together in the safest and smartest way possible.

Maj. Kevin Butler and Maj. Frank Foss are Army Special Forces officers currently pursuing a masters in Defense Analysis at the Naval Postgraduate School. Between them, they have over a dozen combat and operational deployments to the Central Command and Southern Command.

Disclaimer: The views expressed in this article are the views of the authors alone. They do not reflect the official position of the Naval Postgraduate School, the U.S. Army, the Department of Defense, or any other entity within the U.S. government and the authors are not authorized to provide any official position of these entities.

Image: U.S. Army (Photo by Sgt. Apolonia Gaspar)

Originally posted here:
Humans and Hardware: How Special Operations Can Pioneer Wearable Technology - War on the Rocks


Halting COVID-19 in its tracks – UBC Faculty of Medicine

Sunday, November 7th, 2021

Nearly two years into the global pandemic, there remain a handful of approved therapies to treat COVID-19.

Dr. Dermot Kelleher

And with emerging variants threatening the effectiveness of existing vaccines, there is an ever-pressing need to find new treatment approaches to fight the disease.

At UBCs faculty of medicine, researchers Dr. Dermot Kelleher and Dr. Shane Duggan are tackling this challenge head on, redirecting elements of their groundbreaking research on esophageal disease to develop a novel aerosol treatment for COVID-19.

The global effort to intervene in the spread and severity of COVID-19 has produced several effective vaccines, but there is still a pressing need for new treatments for people who contract the virus and to safeguard the health and well-being of those who are most vulnerable to disease transmission, says Dr. Kelleher, dean of the faculty of medicine and vice-president, health at UBC.

The proposed therapyset to be delivered to the lungs as an aerosol using a handheld nebulizerwould be designed to stop the virus from replicating, halting the progression of COVID-19 in an effort to reduce harmful health effects and save lives.

The global effort to intervene in the spread and severity of COVID-19 has produced several effective vaccines, but there is still a pressing need for new treatments for people who contract the virus and to safeguard the health and well-being of those who are most vulnerable to disease transmission. Dr. Dermot Kelleher

The researchers are hopeful that the treatment could help reduce hospitalizations and one day delay or even eliminate the need for mechanical ventilators for patients who contract the disease. They also see great potential for the therapy to be used as a prophylactic, or preventative treatment, capable of temporarily reducing the risk of infection and protecting healthcare workers on the frontlines as well as others at increased risk.

This is an excellent example of the world-class biomedical research taking place at UBCs Academy of Translational Medicine (ATM), says Dr. Poul Sorensen, director of the ATM. The ATM is a powerful innovation hub dedicated to accelerating the translation of scientific discoveries into clinical practice, rapidly solving some of lifes most pressing health challengesfrom COVID-19 and cancer to diabetes and dementiabringing real and lasting hope to everyone.

This research also nicely complements the groundbreaking work underway in Dr. Josef Penningers laboratory at UBCs Life Sciences Institute (LSI), where they are examining the use of an inhalable form of the ACE2 protein to bind the virus and halt COVID-19, adds Dr. Sorensen.

Within UBCs Life Sciences Institutethe largest biomedical research institute of its kind in Canadathe research team is already hard at work in the Kelleher lab, using cutting-edge technology to identify and design molecules to target SARS-CoV-2, the virus that causes COVID-19.

Once inhaled, these specialized molecules, known as GapmeRs, would stick to the virus and degrade its DNA, thereby preventing the virus from replicating further, while limiting infection and further transmission.

Dr. Shane Duggan

Ultimately, by embracing GapmeR technology and a simple delivery system, such as a nebulizer that doesnt rely on specialized equipment, the researchers believe their approach could represent a much more cost-effective means of combatting COVID-19 and saving lives around the worldincluding harder-to-reach regions.

Its our duty as researchers to use every tool in our toolkit to advance knowledge of COVID-19 and rapidly rethink our current treatment approaches to make a direct impact on patient lives both here in Canada and around the world. Dr. Shane Duggan

Treatments based on GapmeR technology are relatively easy to manufacture and require no specialized storage or transport, which make them ideal for distributing to vulnerable communities in need, says Dr. Duggan, a research associate in the division of gastroenterology.

In the coming months, the research team, which has recently grown to include two postdoctoral fellows with expertise in virology, will begin rapidly identifying molecular candidates with the highest chance of success. Following this, they will begin working with the live virus.

In an effort to accelerate the development of the new treatment, the UBC research team will also collaborate with a group of scientists with expertise in GapmeR technologies led by Dr. Navin Verma at the Lee Kong Chian School of Medicine, Nanyang Technological University in Singapore. Through this international partnership, the team hopes to bolster the studies needed to turn their research into a clinical reality, ultimately expediting the path from bench to bedside.

Beyond COVID-19, the treatment approach has the potential to be rapidly mobilized and tailored to fight future viral outbreaksand could one day be used to help tackle other diseases, including some forms of cancer.

The beauty behind this technology is that it holds tremendous potential because its readily translatable and scalable, says Dr. Duggan.

But right now, with COVID-19 forecasted to remain for the foreseeable future, the research team remains focused on the current pandemic and accelerating an aerosol treatment to save lives.

COVID-19 has already claimed the lives of millions and impacted millions more around the world, says Dr. Duggan, who, after losing a family member to a combination of COVID-19 and liver dysfunction last year, understands the high stakes at hand more than most.

Its our duty as researchers to use every tool in our toolkit to advance knowledge of COVID-19 and rapidly rethink our current treatment approaches to make a direct impact on patient lives both here in Canada and around the world.

At UBC, this is hope, accelerated.

Read the original post:
Halting COVID-19 in its tracks - UBC Faculty of Medicine


Preventive Medicine Residency Programs | ACPM

Friday, October 15th, 2021

Preventive medicine is a specialty that bridges clinical practice and public health. Specialists work in diverse settings and tap into a broad skill set to prevent disease and promote the health of individuals, communities and populations.

Physicians completing a preventive medicine residency gain a breadth of skills that opens many potential career paths in population health system management, public health and epidemiology, clinical care, health informatics, public health policy development and much more. Preventive medicine physicians work in a variety of settings including state and local health departments, Fortune 100 companies, health systems and all levels of government.

Click HERE to download a full list of Preventive Medicine Residency Programs.

Completion of residency training in preventive medicine is an essential step to become certified in one or more of the preventive medicine specialty areas: Public Health and General Preventive Medicine, Occupational Medicine, and Aerospace Medicine.

There are currently 72accredited preventive medicine residency training programs in the United States. Programs are administered by schools of medicine, schools of public health, state or local health departments, or in federal government agencies or branches of the uniformed services. They take an individualized approach to training, with approximately 350 residents in training every year.

Residency program accreditation and ongoing compliance reviews are performed by the Preventive Medicine Residency Review Committee of the Accreditation Council for Graduate Medical Education (ACGME).

Prospective residents must contact their desired residency programs directly for information and application instructions. Program directors may connect residents with program match specialists who can provide additional information and guidance. Many programs participate in the Preventive Medicine Electronic Residency Application Service.

ACPM administers a voluntary standardized acceptance process for General Preventive Medicine and Public Health residency programs. This centralized service provides the participating programs with a uniform method of selecting residents. ACPM opens registration in October and application review begins the following January.

Prior to an appointment in a preventive medicine residency program, applicants must have successfully completed at least 12 months of clinical education in a residency program accredited by the ACGME, Royal College of Physicians and Surgeons of Canada, or the College of Family Physicians of Canada.

Experience must include at least 11 months of direct patient care, in both inpatient and outpatient settings, where residents developed competency in the following clinical skills:

In addition to the base skills related to clinical practice, preventive medicine residency programs feature competencies in the following areas:

Two-year training programs include didactics, clinical training, research, public health and other population-based experiences. The didactic training includes both residency-lead seminars, as well as the acquisition of a Master in Public Health or equivalent degree. Those residents entering with an appropriate degree can enhance their didactics with additional coursework. Whether through a Master in Public Health or other equivalent degree, all residents must complete graduate level courses in epidemiology, biostatistics, health services management and administration, environmental health and the behavioral aspects of health.

Practicum experiences can take place across the two years of the residency and include acquisition of skills in clinical and population prevention medicine. Examples of practicum experiences include appointments in: local, state and federal health departments; health maintenance organizations; peer review organizations; community and migrant health centers; occupational health clinics; industrial sites; regulatory agencies; NASA; OSHA; research settings and many more. Reference the Examples of Preventive Medicine Training Opportunities for a comprehensive listing.

Combined residency training is designed to lead to board certification in two medical specialties. Combined programs may reduce the overall length of required training by as much as one year. Residencies that offer combined training programs must maintain their accreditation status through each specialty Residency Review Committee.

The ABPM and the American Board of Internal Medicine have formal guidelines for a combined 4-year residency training program, which leads to board certification in both Preventive Medicine and Internal Medicine.

Several institutions also offer 4-year programs with combined training in preventive medicine and family medicine.

The preventive medicine Standardized Acceptance Process (SAP) is a service offered by ACPM to aid in matching prospective preventive medicine residents with available positions at residency programs across the country. The SAP helps to create homogeneity in residency program acceptance timetables, and ensures programs and candidates have adequate time to complete interviews and make and accept offers.Since 2018, nearly three quarters of all General Preventive Medicine and Public Health residency programs have participated in the SAP match.

SAP policy information, program guidelinesand resources for 2022 will be posted soon.

October - November - Programs Register for the SAP

October- January, 2022 - Applicants Register for the SAP

November 12 - Program InformationalSession

November 19 - Applicant Informational Session

January 24 - 28,2022- Applicants submit ranked lists

February 1- 4,2022- Programs submit ranked lists

February 7 - 11, 2022 - SAP pairing period

Accordion toggle

Previous Slide

Next Slide

Accordion toggle

Previous Slide

Next Slide

Originally posted here:
Preventive Medicine Residency Programs | ACPM


Preventive Medicine Services Reporting – AAPC Knowledge Center

Friday, October 15th, 2021

Preventive medicine services, or well visits, are evaluation and management (E/M) services provided to a patient without a chief complaint. The reason for the visit is not an illness or injury (or signs or symptoms of an illness or injury), but rather to evaluate the patients overall health, and to identify potential health problems before they manifest.The CPT code book includes a dedicated set of codes to describe preventive medicine services:

99381 Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; infant (age younger than 1 year)99382 early childhood (age 1 through 4 years)99383 late childhood (age 5 through 11 years)99384 adolescent (age 12 through 17 years)99385 18-39 years99386 40-64 years99387 65 years and older99391 Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year)99392 early childhood (age 1 through 4 years)99393 late childhood (age 5 through 11 years)99394 adolescent (age 12 through 17 years)99395 18-39 years99396 40-64 years99397 65 years and older

Code assignment is determined by the patients age (as detailed in the code descriptor), and whether the patient is new (99381-99387) or established (99391-99397). CPT applies the three year rule to determine new vs. established status. A patient is established if any physician in a group practice (or, more precisely, any physician of the same specialty billing under the same group number) has seen that patient for a face-to-face service within the past 36 months. The Decision Tree for New Vs Established Patients in the Evaluation and Management Services Guidelinesportion of the CPT code book can help you to select the appropriate patient status.Service Content Varies by Patient CircumstancePreventive medicine services must include a comprehensive history and examination, and age-appropriate anticipatory guidance. In the context of preventive medicine services 99381-99397, a comprehensive exam is not the comprehensive exam as defined by either the 1995 or 1997 Evaluation and Management Documentation Guidelines. Instead, the exam should reflect an appropriate assessment, given the specific patients age and sex. For example, the specifics of the exam will differ for a 4-yr-old male and a 22-year-old female.Services for a young child will assess physical growth (height, weight, head circumference) and developmental milestones such as speech, crawling, and sleeping habits. Anticipatory guidance may include use of car seats and other safety issues, introducing new foods, etc.An adolescent preventive service may include scoliosis screening, assessment of growth and development, and a review of immunizations. Anticipatory guidance may focus on developing positive health habits and self-care, including discussion of drug, alcohol, and tobacco use, and sexual activity.A comprehensive preventive visit for an adult female patient will include a gynecologic examination, Pap smear, and breast exam. An adult males exam would include an examination of the scrotum, testes, penis, and the prostate for older patients. Anticipatory guidance may focus on issues of health maintenance, such as alcohol and tobacco use, safe sex practices, nutrition, and exercise. The patients employment status and other family issues may be discussed. As patient age advances, cholesterol levels, blood sugar, and prostate-specific antigen(PSA) testing may become increasingly relevant.Diagnoses Must Support Preventive Nature of the VisitEvery billed service must be supported by an ICD-10-CM code(s) that describe the reason for that service. In the case of a well visitbecause there is no patient complaintyou should turn to so-called Z codes (Factors influencing health status and contact with health services). For example:

Z00.110 Health examination for newborn under 8 days oldZ00.111Health examination for newborn 8 to 28 days oldZ00.121 Encounter for routine child health examination with abnormal findingsZ00.129Encounter for routine child health examination without abnormal findingsZ00.00 Encounter for general adult medical examination without abnormal findingsZ00.01 Encounter for general adult medical examination with abnormal findingsZ01.411 Encounter for gynecological examination (general) (routine) with abnormal findingsZ01.419 Encounter for gynecological examination (general) (routine) without abnormal findings

You also should code for any abnormalities found, regardless of whether the finding requires an additionally reported service.Testing and Problem-Focused Testing Are SeparatePer CPT coding guidelines:If an abnormality is encountered or a preexisting problem is addressed in the process of performing this preventive medicine evaluation and management service, and if the problem or abnormality is significant enough to require additional work to perform the key components of a problem-oriented E/M service, then the appropriate Office/Outpatient code 99201-99215 should also be reported. Modifier 25 should be added to the office/outpatient code to indicate that a significant, separately identifiable evaluation and management service was provided on the same day as the preventive medicine service.To determine whether a problem requires significant work, consider whether the available documentation is sufficient to support each service (the preventive service and the problem-oriented service), separately.Additionally, per CPT coding guidelines, as supported by CPT Assistant(April 2005):

The codes in the preventive medicine services include the ordering of appropriate immunization(s) and laboratory or diagnostic procedures. The performance of immunization and ancillary studies involving laboratory, radiology, other procedures, or screening tests identified with a specific CPT code are reported separately.

Payer Coverage May VaryThe Affordable Care Act (ACA) requires insurers to cover recommended preventive services without any patient cost-sharing, but exact coverage and reporting requirements may vary from payer to payer. As CPT Assistant(April 2005) notes:

Codes 99381-99397 are used to report the preventive evaluation and management (E/M) of infants, children, adolescents, and adults. The extent and focus of the services will largely depend on the age of the patient. For example, E/M preventive services for a 28-year-old adult female may include a pelvic examination including obtaining a pap smear, breast examination, and blood pressure check. Counseling is provided regarding diet and exercise, substance use, and sexual activity.

Based upon this information, it is not be appropriate to separately report for a pelvic exam including obtaining of the pap smear, nor the breast exam as these services are considered part of a comprehensive preventive medicine E/M services.Although this reporting method reflects the intent of CPT coding guidelines, third-party payers may request that preventive medicine services be reported differently. Third-party payers should be contacted for their specific reporting guidelines.Authors Note:Although the CPT Assistantarticle cited pre-dates the ACA, the advice to contact your payers regarding their reporting requirements remains valid.Be aware, as well, that Medicare reporting requirements, as stipulated by the Centers for Medicare & Medicaid Services (CMS) often differ from CPT guidelines. For more information about Medicare Preventive Medicine Services and Screenings, visit the CMS website.

John Verhovshek, MA, CPC, is a contributing editor at AAPC. He has been covering medical coding and billing, healthcare policy, and the business of medicine since 1999. He is an alumnus of York College of Pennsylvania and Clemson University.

See the rest here:
Preventive Medicine Services Reporting - AAPC Knowledge Center


Healthcare Conferences and Preventive Medicine Conferences …

Friday, October 15th, 2021

Scope & Importance


We work hard to improve the lives of our patients and their families by collaborating with the healthcare community. We offer clinical experience to both allied health professionals and patients.

We focus on the right to comprehensive, high-quality primary care for individuals and populations.

To provide the most safest, ethical, and effective medical care possible. Practice the safest, most ethical and effective medical care possible. Breakthrough research can lead to the discovery of new treatments and therapies. Promoting healthy and reducing health disparities. Educate and inspire faculty, healthcare developers, policy makers and leaders of the next generation. Build a philanthropic culture for patient care and research.


Our objective is to disseminate healthcare information and innovations that will guide in a new era of medicine.

Healthcare Market Forecast

Healthcare is one of those industries that has never seen ups and downs, particularly since technology has taken over its progress.Even throughout the pandemic, technology was important in advancing healthcare to a higher level.

In 2019, the global home healthcare market was valued at USD 281.8 billion, with a compound annual growth rate (CAGR) of 7.9% predicted from 2020 to 2027. Market growth is expected to be increased by global population ageing and rising patient preference for value-based healthcare. In 2019, the World Health Organization (WHO) estimated that 703 million people aged 65 and up lived in the world. By 2050, the number of elderly people is expected to increase to 1.5 billion. The ageing population necessitates more patient-centric healthcare services, which in turn raises demand for healthcare personnel and agencies, drive market growth.

Medicare is the largest single payer of home healthcare services in the United States. Medicare accounts for more than 40% of all home health care expenses.

Healthcare Market Overview in USA

The home healthcare market is divided into two components: equipment and services, wherein the services segment dominated the market with a share of 80% in 2019. The demand for home healthcare agencies is increasing as the world's population ages, resulting in better patient outcomes. Furthermore, the rising frequency of chronic diseases among the elderly is a prominent factor contributing to market growth.

In 2019, therapeutic devices dominated the equipment market. The growing number of patients with chronic or severe respiratory infections, urinary infections, or end-stage renal disease (ESRD) necessitates the use of innovative devices for treatment. Another important element driving the therapeutic equipment market is lower service rates for in-home healthcare when compared to hospitals or nursing homes. End-stage renal diseases (ESRD) affects roughly 750,000 persons in the United States each year, and 2 million patients worldwide, according to the University of California, San Francisco

The diagnostics equipment market is expected to develop at a healthy rate over the projected period, owing to the rising prevalence of diabetes and cardiovascular illnesses, both of which necessitate constant monitoring. Furthermore, increasing patient awareness of the screening process and technological advancements, such as the integration of microfluidics, sensors, the Internet of Things (IoT), smartphones, and wearables, provide point-of-care testing to patients and represent a significant opportunity for providing sensitive, low-cost, rapid, and connected diagnostics.

In 2019, North America dominated the home healthcare industry with a 42% share. In 2019, the United States had the greatest market share in North America, due to changing trends towards in-home healthcare from nursing homes, technology advancements, and the presence of modern medical infrastructure. In addition, the region's market is being driven by high patient awareness levels, rising healthcare expenses, and the deployment of a streamlined regulatory framework. Profits in the U.S. healthcare industry are expected to grow at a 5% annual rate through 2024, with medtech and healthcare IT experiencing the fastest growth. Profits in healthcare information technology are expected to rise from 14 billion US dollars in 2019 to 28 billion US dollars in 2024.

Healthcare Market Overview in Japan

Japan is the world's second-largest market for medical devices and healthcare. Japan is open to innovative and high-quality products and technologies, with nearly 45% of medical devices imported.

By nearly 180,000 medical facilities, including hospitals and clinics, Japan has the world's second largest healthcare market. In fiscal FY 2010, national medical expenditure was 37.4 trillion (approx 249 billion @150 = 1), a 3.9 percent increase over the previous year. This was a record-high in terms of both level and rate of growth, driven by the implementation of cutting-edge medical technologies as well as one of the world's fastest ageing populations. As a result of the ageing population, demand for assistive and care products has increased. However, the market is already crowded with a wide range of products, making it extremely difficult for new entrants lacking unique selling points.

The Japanese medical device market is also the world's second largest, valued at 2.4 trillion yen (approx. 16 billion) in 2011, with foreign manufacturers accounting for 44.4 percent of the products. Japan has long been known as a high-tech nation, but the market for medical devices is still heavily reliant on imports.

Healthcare Market Overview in Europe

Despite rising global trade tensions and a sluggish global economic outlook for 2020, the global healthcare market is expected to surpass $2 trillion in 2020. BREXIT is expected to have a significant impact on the United Kingdom, Europe's largest digital healthcare market.

In the forecast period of 2020 to 2027, the healthcare IT market is expected to grow. According to Data Bridge Market Research, the market will be worth USD 150.97 billion by 2027, growing at a CAGR of 15.62 percent during the forecast period.

The European healthcare market is expected to grow from approximately $2080 billion in 2016 to approximately $2125 billion in 2020. The European healthcare market is expected to exceed US$ 224 billion by 2022.

The European home healthcare market was worth USD 70.28 billion in 2019 and is expected to grow at an 8.37 percent CAGR to reach USD 105.04 billion by 2024.

In 2019, Germany had the highest market share in Europe, followed by France. This is mostly due to rising in-home healthcare spending in the country and rising demand for the skilled nursing workers to provide in-home care.

Healthcare Market Overview in Australia

The health care and social assistance industry is Australia's largest employer. This industry employed over 1.7 million people in 2020, with a projected increase to more than 1.9 million by 2024.

Occupations related to the HLT Health Training Package account for roughly one-third of the workforce in Health Care and Social Assistance. The occupations with the highest proportion of the workforce are Aged and Disabled Carers and Nursing Support and Personal Care Workers. Both are expected to grow significantly until 2024, with Aged and Disabled Carers growing by more than 25%. Other occupations in this sector are expected to grow to varying degrees as well. Welfare Support Workers, for example, are expected to grow by nearly 23%, Health and Welfare Services Managers by about 19%, and Complementary Health Therapists by about 15%.

Medical device industry overview: The medical device sector in Australia is mature, with a well-developed regulatory system. However, in the next years, it will be one of the slowest-growing economies in the South Pacific area. In 2016, the market was worth $4 billion, down from $5 billion in 2014. Due to Australia's sinking currency, market recovery will be delayed in 2019. Despite its low growth, Australia's ageing population, Federal Budget measures, and openness to adopt new technology should help to stabilise the market.

Australian market opportunities: Australia's healthcare business is sophisticated and open to innovative products. A wide range of medical gadgets, particularly those designed to treat and manage age-related disorders, are in high demand. Because the Australian market is pushed to cut prices, imported devices are frequently inventive and cost-effective. In addition, there is a growing demand for gadgets that help people with disabilities and chronic pain, as well as those that help them recover faster. The Australian market is highly accessible from a regulatory aspect for items that already have CE Marking.

Healthcare Market Overview in Middle East

Healthcare prospects are expanding across the Middle East. According to a recent analysis by the US-UAE Business Council, healthcare spending in the UAE is forecast to rise from $17 billion in 2017 to $21.3 billion by 2021, with a CAGR of 8.5 percent predicted between 2018 and 2023 in the UAE Healthcare Sector Outlook 2023 report.

Aging populations, longer life expectancies, and sedentary lifestyles, all of which contribute to an increase in obesity, cancer, and diabetes, are driving demand growth. New modes of care and out-of-hospital services are emerging as a result of an emphasis on prevention and well-being rather than simply treating patients. Saudi Arabia, for example, is developing a new healthcare system that includes primary, community, and secondary care.

Simultaneously, labour challenges, such as a lack of competent clinical staff and a strong reliance on expatriates, are pushing demand for technology such as digital health, artificial intelligence, and robots to fill the gap. By 2025, the region's medical technology market is estimated to be worth $31.6 billion.

The size of the Middle East and Africa Home Healthcare Market was worth USD 21.62 billion in 2020 and estimated to be growing at a CAGR of 9.30%, to reach USD 33.32 billion by 2025 during the forecast period.

These countries are expected to have a market size of USD 102 billion in 2024 with a CAGR value of 9.2% during the forecast period. Healthcare is the fastest-growing sector in the UAE, accounting for 79% of the market.

Healthcare Market Overview in APAC

The size of the home Healthcare Market in the Asia Pacific was worth USD 43.25 billion in 2020 and estimated to be growing at a CAGR of 12.56% to each USD 78.14 billion by 2025.

Home Healthcare Market Report Scope

Report Attribute


Market size value in 2020

USD 303.6 billion in 2020

Revenue forecast in 2027

USD 515.6 billion

Growth Rate

CAGR of 7.9% from 2020 to 2027

Max Seats15 seats

Speaker Time20 mins

Go here to read the rest:
Healthcare Conferences and Preventive Medicine Conferences ...


Aspirin No Longer Recommended as a Preventative Measure Against Heart Attacks and Strokes in Older Individuals – Smithsonian

Friday, October 15th, 2021

Low-dose aspirin or baby aspirin (81 to 100 milligrams) has been used as a safe and cheap way to reduce the risk of cardiovascular diseases, heart attacks, strokes, and blood clots. Aspirin does this by thinning out the blood and preventing blood clots from forming, which may block arteries. Getty images

The United StatesPreventive Services Task Force (USPTF) released adraft guidelineon October 12 stating that a daily regimen of low-dose aspirin is no longer recommended as a preventative measure to reduce the risk of cardiovascular problems in older adults without heart disease, reports Lindsey Tanner for theAssociated Press.

Individuals over 60 should not take preventive aspirin because of the age-related risk for life-threatening bleeding. The guidelines are not yet final but may affect tens of millions of adults at high risk for cardiovascular disease, reports Roni Caryn Rabin for theNew York Times.

Ultimately, those currently on a low-dose aspirin regimen or who have cardiovascular risk factors should talk to their doctors about what is best for them.

We dont recommend anyone stop without talking to a clinician, and definitely not if they have already had a heart attack or stroke, says Chien-Wen Tseng, a USPTF memberand a University of Hawaii research director, to theNew York Times.

The report also states that those aged between 40 and 60 and worried about their heart health should decide to take aspirin on a case-by-case basis, reports Ed Cara forGizmodo.

The panel consists of 16 medicine and disease prevention experts who evaluate evidence-based preventative measures and screening tests. Panel members are appointed by theAgency for Healthcare Research and Quality.

Low-dose aspirin or baby aspirin (81 to 100 milligrams) has previously been recommended as a safe and cheap way to reduce the risk of cardiovascular diseases, heart attacks, strokes, and blood clots. Aspirin does this by thinning out the blood and preventing blood clots from forming, per theNew York Times. The drugseems to most help individuals who already have, or are at a high riskfor, cardiovascular disease.The panel found some evidence that baby aspirin may only benefit people between 40 and 60 years of age who have a 10 percent risk of having a heart attack or stroke, per the Associated Press.

However, aspirin can also cause life-threatening bleeding inthe digestive tractor brain, per the New York Times. One study published in 2018 in theNew England Journal of Medicinefound that the risk of bleeding from an aspirin regimen outweighs its potentialbenefits for those over 70 years of age,Gizmodoreports.

The USPTF made their assessments based on a literature review of data from recent trials and population studies.For older people who have no risks of heart disease, the potential for bleeding damageoutweighs any aspirin benefits.

When we looked at the literature, most of it suggested the net balance is not favorable for most people there was more bleeding than heart attacks prevented, says Amit Khera, an author of the guideline, to theNew York Times. And this isnt nose bleeds, this can be bleeding in the brain.

The draft recommendation statement is currently open for public comment until November 8, before a final version of the report Is published, theNew York Timesreports.

Theres no longer a blanket statement that everybody whos at increased risk for heart disease, even though they never had a heart attack, should be on aspirin, Tseng explains to theNew York Times. We need to be smarter at matching primary prevention to the people who will benefit the most and have the least risk of harm.

Visit link:
Aspirin No Longer Recommended as a Preventative Measure Against Heart Attacks and Strokes in Older Individuals - Smithsonian


What you need to know about the coronavirus right now – Yahoo News

Friday, October 15th, 2021

(Reuters) - Here's what you need to know about the coronavirus right now:

Merck seeks first U.S. FDA authorization for COVID-19 tablet

Merck & Co said on Monday it has applied for U.S. emergency use authorization for its tablet to treat mild-to-moderate patients of COVID-19, putting it on course to become the first oral antiviral medication for the disease.

Its authorization could help change clinical management of COVID-19 as the pill can be taken at home. The treatment, molnupiravir, could halve the chances of death or being hospitalized for those most at risk of contracting severe COVID-19, according to the drugmaker.

The interim efficacy data on the drug, which has been developed with Ridgeback Biotherapeutics, had heavily impacted the shares of COVID-19 vaccine makers when it was released last week.

AstraZeneca antibody cocktail succeeds in late-stage study

AstraZeneca's experimental COVID-19 drug has helped cut the risk of severe disease or death in a late-stage study, the British drugmaker said on Monday, a boost to its efforts to develop coronavirus medicines beyond vaccines.

The drug, a cocktail of two antibodies called AZD7442, reduced the risk of severe COVID-19 or death by 50% in non-hospitalised patients who have had symptoms for seven days or less, meeting the main goal of the study.

AstraZeneca's therapy, delivered via injection, is the first of its kind to show promise both as a preventative medicine and as a treatment for COVID-19 following multiple trials. It is designed to protect people who do not have a strong enough immune response to vaccines.

Sydney reopens as Australia looks to live with COVID-19

Sydney's cafes, gyms and restaurants welcomed back fully vaccinated customers on Monday after nearly four months of lockdown, as Australia aims to begin living with the coronavirus and gradually reopen with high rates of inoculation.

Some pubs in Sydney, Australia's largest city, opened at 12:01 a.m. (1301 GMT Sunday) and friends and families huddled together for a midnight beer.

Story continues

"I see it as a day of freedom, it's a freedom day," New South Wales state Premier Dominic Perrottet told reporters in Sydney, the state capital. "We are leading the nation out of this pandemic but this will be a challenge."

New Zealand makes vaccinations mandatory for health workers

New Zealand will require teachers and workers in the health and disability sectors to be fully vaccinated against COVID-19, Prime Minister Jacinda Ardern said on Monday, as she extended restrictions in Auckland, its largest city, for another week.

New Zealand is fighting the highly infectious Delta outbreak that forced it to abandon its long-standing strategy of eliminating the new coronavirus amid persistent infections.

"New Zealand is at one of the trickiest and most challenging moments in the COVID-19 pandemic so far," Ardern told reporters in Wellington. Ardern, however, said "there is a clear path forward" in the next few months to live with fewer curbs and more freedoms once the country reaches a higher level of vaccinations.

Russia's daily death toll hovers near all-time high

Russia reported 957 coronavirus-related deaths on Monday, close to the all-time high of 968 reported two days earlier.

The government coronavirus task force also said it had recorded 29,409 new cases in the last 24 hours, an increase from 28,647 cases on Sunday.

(Compiled by Linda Noakes; Editing by Alex Richardson)

Continued here:
What you need to know about the coronavirus right now - Yahoo News


Geoengineering: We should not play dice with the planet | TheHill – The Hill

Friday, October 15th, 2021

The fate of the Biden administrations agenda on climate remains uncertain, captive to todays toxic atmosphere in Washington, DC. But the headlines of 2021 leave little in the way of ambiguity the era of dangerous climate change is already upon us, in the form of wildfires, hurricanes, droughts and flooding that have upended lives across America. A recent UN report on climate is clear these impacts will worsen in the coming two decades if we fail to halt the continued accumulation of greenhouse gases in the atmosphere.

To avert disaster, we must chart a different climate course, beginning this year, to achieve steep emissions reductions this decade. Meeting this moment demands an all hands-on-deck approach. And no stone should be left unturned in our quest for meaningful options for decarbonizing our economy.

But while it is tempting to pin our hopes on future technology that might reduce the scope of future climate damages, we must pursue such strategies based on sound science, with a keen eye for potential false leads and dead ends. And we must not allow ourselves to be distracted from the task at hand reducing fossil fuel emissions by technofixes that at best, may not pan out, and at worst, may open the door to potentially disastrous unintended consequences.

So-called geoengineering, the intentional manipulation of our planetary environment in a dubious effort to offset the warming from carbon pollution, is the poster child for such potentially dangerous gambits. As the threat of climate change becomes more apparent, an increasingly desperate public and the policymakers that represent them seem to be willing to entertain geoengineering schemes. And some prominent individuals, such as former Microsoft CEO Bill Gates, have been willing to use them to advocate for this risky path forward.

The New York Times recently injected momentum into the push for geoengineering strategies with a recent op-ed by Harvard scientist and geoengineering advocate David Keith. Keith argues that even in a world where emissions cuts are quick enough and large enough to limit warming to 1.5 degrees Celsius by 2050, we would face centuries of elevated atmospheric CO2 concentrations and global temperatures combined with rising sea levels.

The solution proposed by geoengineering proponents? A combination of slow but steady CO2 removal factories (including Keiths own for-profit company) and a quick-acting temperature fix likened to a band-aid delivered by a fleet of airplanes dumping vast quantities of chemicals into the upper atmosphere.

This latter scheme is sometimes called solar geoengineering or solar radiation management, but thats really a euphemism for efforts to inject potentially harmful chemicals into the stratosphere with potentially disastrous side effects, including more widespread drought, reduced agricultural productivity, and unpredictable shifts in regional climate patterns. Solar geoengineering does nothing to slow the pace of ocean acidification, which will increase with emissions.

On top of that is the risk of termination shock (a scenario in which we suffer the cumulative warming from decades of increasing emissions in a matter of several years, should we abruptly end solar geoengineering efforts). Herein lies the moral hazard of this scheme: It could well be used to justify delays in reducing carbon emissions, addicting human civilization writ large to these dangerous regular chemical injections into the atmosphere.

While this is the time to apply bold, creative thinking to accelerate progress toward climate stability, this is not the time to play fast and loose with the planet, in service of any agenda, be it political or scientific in nature. As the recent UN climate report makes clear, any emissions trajectory consistent with peak warming of 1.5 degrees Celsius by mid-century will pave the way for substantial drawdown of atmospheric CO2 thereafter. Such drawdown prevents further increases in surface temperatures once net emissions decline to zero, followed by global-scale cooling shortly after emissions go negative.

Natural carbon sinks over land as well as the ocean play a critical role in this scenario. They have sequestered half of our historic CO2 emissions, and are projected to continue to do so in coming decades. Their buffering capacity may be reduced with further warming, however, which is yet another reason to limit warming to 1.5 degrees Celsius this century. But if we are to achieve negative emissions this century manifest as steady reductions of atmospheric CO2 concentrations it will be because we reduce emissions below the level of uptake by natural carbon sinks. So, carbon removal technology trumpeted as a scalable solution to our emissions challenge is unlikely to make a meaningful dent in atmospheric CO2 concentrations.

As to the issue of climate reversibility, its nave to think that we could reverse nearly two centuries of cumulative emissions and associated warming in a matter of decades. Nonetheless, the latest science tells us that surface warming responds immediately to reductions in carbon emissions. Land responds the fastest, so we can expect a rapid halt to the worsening of heatwaves, droughts, wildfires and floods once we reach net-zero emissions. Climate impacts tied to the ocean, such as marine heat waves and hurricanes, would respond somewhat more slowly. And the polar ice sheets may continue to lose mass and contribute to sea-level rise for centuries, but coastal communities can more easily adapt to sea-level rise if warming is limited to 1.5 degrees Celsius.

While its appealing to think that a climate band-aid could protect us from the worst climate impacts, solar geoengineering is more like risky elective surgery than a preventative medicine. This supposed climate fix might very well be worse than the disease, drying the continents and reducing crop yields, and having potentially other unforeseen negative consequences. The notion that such an intervention might somehow aid the plight of the global poor seems misguided at best.

When considering how to advance climate justice in the world, it is critical to ask, Who wins and who loses? in a geoengineered future. If the winners are petrostates and large corporations who, if history is any guide, will likely be granted preferred access to the planetary thermostat, and the losers are the global poor who already suffer disproportionately from dirty fossil fuels and climate impacts then we might simply be adding insult to injury.

To be clear, the world should continue to invest in research and development of science and technology that might hasten societal decarbonization and climate stabilization, and eventually the return to a cooler climate. But those technologies must be measured, in both efficacy and safety, against the least risky and most surefire path to a net-zero world: the path from a fossil fuel-driven to a clean energy-driven society.

Kim Cobb is the director of the Global Change Program at the Georgia Institute of Technology and professor in the School of Earth and Atmospheric Sciences. She was a lead author on the recent UN Intergovernmental Panel on Climate Change (IPCC) Sixth Assessment Report. Follow her on Twitter: @coralsncaves

Michael E. Mann is distinguished professor of atmospheric science and director of the Earth System Science Center at Penn State University. He is author of the recently released book,The New Climate War: The Fight to Take Back our Planet. Follow him on Twitter:@MichaelEMann

See the original post:
Geoengineering: We should not play dice with the planet | TheHill - The Hill


What Taking a Vitamin Every Day Does to Your Body – Yahoo Lifestyle

Friday, October 15th, 2021

When it comes to our health, just about everyone is looking for an extra boostparticularly during the COVID-19 pandemic. That desire has helped vitamins and supplements grow into a $150 billion worldwide industry. If you're considering taking a daily vitaminor are taking one nowit's important to know there are clear things vitamins can and can't do, as indicated by decades of research. And if you take them the wrong way, they can be harmful. Read on to find out what taking a daily vitamin does to your bodyand to ensure your health and the health of others, don't miss these Sure Signs You May Have Already Had COVID.

Woman taking her medication in her bedroom at home.

"If you're like everybody else in the world, and you don't eat a perfect diet every day, a multivitamin is going to fill in the little deficits you have on a daily basis," Kathryn Boling, MD, a family medicine doctor with Mercy Medical Center in Baltimore, told ETNT Health. "And if you're OK paying money for something that you're mostly going to pee out, but it's going to fill in those tiny little deficits, then take a multivitamin. I do."

RELATED: Health Habits You Should Avoid if Over 50

vitamin d

If your daily multivitamin contains vitamins C and D (and most do), those nutrients may support your immune system. "If you're deficient in vitamin D, that does have an impact on your susceptibility to infection," said Dr. Anthony Fauci, the nation's top infectious-disease specialist, in an interview last fall. "I would not mind recommendingand I do it myselftaking vitamin D supplements."

He added: "The other vitamin that people take is vitamin C because it's a good antioxidant, so if people want to take a gram or so of vitamin C, that would be fine."

RELATED: Everyday Habits That Add Years to Your Life, Say Experts

Story continues

Man sitting at the table and taking vitamin D

You might erase potential benefits from vitamins if you chase them with soda and sugary snacks, or use them as justification for too many cheat meals. "Supplements are never a substitute for a balanced, healthful diet," said Dr. JoAnn Manson, a preventative medicine specialist, in an interview with Harvard Health. "And they can be a distraction from healthy lifestyle practices that confer much greater benefits."

RELATED: Forgetting This One Thing Can Mean You Have Alzheimer's

young woman with stomach pain

If your vitamin contains high doses of certain nutrients, that can cause problems. Most vitamins are water-soluble, meaning they can't build up in the body because any excess is cleared by urine. But fat-soluble vitamins including A, D, E and K can build up in the body and may be dangerous at high levels, particularly A and E.

RELATED: Common Habits That Age You Faster, According to Science

Shot of woman nutritionist doctor writes the medical prescription for a correct diet on a desk with fruits, pills and supplements.

If you're taking multivitamins for protection against serious disease, you should know that the science isn't quite there yet. In 2018, researchers from Johns Hopkins analyzed studies involving almost half a million people; they determined that taking multivitamins doesn't lower your risk of heart disease, cancer, cognitive decline, or early death. Their advice: Don't waste your money on multivitaminsget the vitamins and minerals you need from food. And to get through this pandemic at your healthiest, don't miss these 35 Places You're Most Likely to Catch COVID.

Go here to read the rest:
What Taking a Vitamin Every Day Does to Your Body - Yahoo Lifestyle


Welcome to the New Era of Vaccine Acceleration – The New Republic

Friday, October 15th, 2021

If we have learned anything about controlling epidemics in the past year, its that its very difficult to halt the spread of disease with vaccines aloneespecially when they first appear. As the vaccines are endorsed, financed, and rolled out, other prevention strategies are key for controlling the illness.

Insecticide-treated bed netsthats what has made the biggest difference in most parts of Africa over the last couple of decades, Clarke said. And they will remain really important, because the insecticide on the bed net kills mosquitoes, and by reducing the number of mosquitoes, even people who dont sleep under the bed net will be protected, whereas a vaccine can only protect the person whos vaccinated.

Anotherstudy published last month found that combining vaccines with preventative drugs roughly doubled protection for kids. This combination can be used in places with clearly defined malaria seasons, particularly tied to the rainy season, where children are at very high risk of dying from the illness. Families were eager to get both the shots and the medications, Clarke said, because they take malaria extremely seriously.

Its imperative to move quickly, particularly when children are dying. Its all the question of investmentif the investment is made into these types of vaccines, it can be done in five years, Kappe said. When you look at, for example, the investments that have been made over a period of a year, a year and a half, in coronavirus vaccinesif the same resources would be thrown at malaria vaccines, I think we would be there already.

Read this article:
Welcome to the New Era of Vaccine Acceleration - The New Republic


Telehealth acts as a preview of the imminent digital revolution in healthcare as AI gains popularity – South China Morning Post

Friday, October 15th, 2021

[Left to Right] Clark Cahill, Manager of Events and Conferences at SCMP, Dr Ngai-tseung Cheung, Head of Information Technology & Health Informatics for the Hospital Authority, Megan Lam, Co-founder & CEO of Neurum Health, and Dr Matthew Man, Chief Executive Officer of Megasoft Limited took a deep dive into the current state of healthcare including the implementation of AI and the Internet of Things (IoT) into the industry in this series.

Dr Ngai-tseung Cheung, Head of Information Technology & Health Informatics for the Hospital Authority, mentioned how Covid-19 has made the close collaboration between the fields of healthcare, computer science, and machine learning even stronger.

Dr Matthew Man, Chief Executive Officer of Megasoft Limited, proposed the industry should start at the bottom [with] frontline staff [as they] have a lot of pain points.

Co-founder & CEO of Neurum Health, Megan Lam, said health and wellness is one size fits one as opposed to one size fits all.

(Left to Right) Joey Liu, Chief of Staff to the CEO at SCMP, and Dr Kee Yuan Ngiam, Group Chief Technology Officer at National University Health System, discussed how the end goal of medicine is to be more proactive and preventative rather than reactive.

Telehealth acts as a preview of the imminent digital revolution in healthcare as AI gains popularity - South China Morning Post


Opinion/McGonigle: It is time to stop fighting – The Providence Journal

Friday, October 15th, 2021

Dr. John McGonigle| Guest columnist

Dr. John McGonigle is an assistant clinical professor of family medicine at the Warren Alpert School of Medicine at Brown University.

I am a board-certified primary care doctor and an assistant clinical professor in family medicine at Brown University. I have been practicing primary care in Rhode Island since starting residency at Memorial Hospital in Pawtucket in 2006. I am educated, trained and schooled in the most powerful system of medicine the world has ever known.

Indeed, I have not infrequently described this system as analogous to the United States military. When Europe was overrun with Nazis, send the U.S. Army in, and tell them to flatten anything that resists. Its great for killing Nazis. As our recently concluded experience in Afghanistan tells us, send the military into a country and ask them to build schools and they will fail miserably. Wrong tool. Unbeatable in war, quiescent in peace.

The United States, Rhode Island, and the rest of the planet have been engaged in an undertaking unparalleled since the Second World War. While the politicians stay at home and dither over strategy, the people go offand fight. We have been asked to operate on a war footing, and whatever our political or social or economic means have enabled us to do we have done. We have cussed, and spit, and sometimes ridiculed higher officers but have done what they have asked, when they have asked, and in whatever spirits we can muster.

Last year was more straightforward in primary care, since it was all triage, all the time. We didnt know much about Sars-Co-V2, and knew less about treatment. Little of its spread, little of its contagion patterns. Our patients knew even less. They brought us unanswerable questions of life and death, and we worked tirelessly keeping the emergency rooms from being tragically overrun. The usual go to the ER for a full assessment when one was uncertain, or too tired to shake the uncertainty, was off limits.

To carry the battlefield the confusion had to be minimized. ER and ICU doctors and nurses fought heroically, in shifts. Primary Care is not adrenaline soaked and filled with mayhem, but it is unrelenting and remorseless. Primary Care makes it possible for ERs and ICUs to function at ALL times, and when Primary Care is overwhelmed like dishes piling up in the restaurant sink the establishment no longer functions anywhere near optimal efficiency.

We are tired from all the fear and we are tired of filling out forms. We are tired of having kept the supply and chow and ambulance lines going to the front for over 21 months now. Like a returning army our people have come home, and many are gravely scarred. For some the wounds are obvious, and the thank you for your services and sorry for your losses are heartfelt. For far too many the wounds are unseeable and barely reachable and require patience, not stitches.

The tidal wave of wounded families that I am seeing is unparalleled in my 15 years of practice. I am seeing the harms within: between parents, parents and children, children, children and schools; between parents and peers; between my patients' blood pressures and their suffocating, sedentary fears; between health-giving practices and the despairs of a war zone.

We have all been hearing about this war we are in and I am tired of hearing about how much preventative care has been deferred and ignored, and how much the mental health and well-being of the nation needs attention. The country is devastated, and to continue to keep it on a war-footing is prolonging the devastation. It is time for COVID to put down its weapons. The eagle has landed. It is time to start building schools.

See the original post:
Opinion/McGonigle: It is time to stop fighting - The Providence Journal


Page 11234..1020..»

2021 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick